Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share (PRLD)

78 filings reported holding PRLD - Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share as of Q3 2024.
Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share (PRLD) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 35,754,682 shares of 44,162,869 outstanding shares and own 81% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (10,909,256 shares), BAKER BROS. ADVISORS LP (10,123,824 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3,766,120 shares), Boxer Capital, LLC (1,708,187 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,097,599 shares), BlackRock, Inc. (1,058,316 shares), VANGUARD GROUP INC (1,021,770 shares), ExodusPoint Capital Management, LP (921,621 shares), Avidity Partners Management LP (890,000 shares), and MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (549,530 shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.